Sarcomeric hypertrophic cardiomyopathy: Genetic profile in a Portuguese population

Elliott, 2008, Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, Eur Heart J, 29, 270, 10.1093/eurheartj/ehm342 Richard, 2006, The genetic bases of cardiomyopathies, J Am Coll Cardiol, 48, A79, 10.1016/j.jacc.2006.09.014 Bos, 2007, Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?, Curr Opin Cardiol, 22, 193, 10.1097/HCO.0b013e3280e1cc7f Erdmann, 2003, Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy, Clin Genet, 64, 339, 10.1034/j.1399-0004.2003.00151.x Richard, 2003, Hypertrophic cardiomyopathy distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy, Circulation, 107, 2227, 10.1161/01.CIR.0000066323.15244.54 Van Driest, 2004, Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, 44, 602, 10.1016/j.jacc.2004.04.039 Van Driest, 2004, Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy, J Am Coll Cardiol, 44, 1903, 10.1016/j.jacc.2004.07.045 Morita, 2006, Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham heart study, Circulation, 113, 2697, 10.1161/CIRCULATIONAHA.105.593558 Olivotto, 2008, Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy, Mayo Clin Proc, 83, 630, 10.1016/S0025-6196(11)60890-2 Maron, 1995, Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (young) adults, Circulation, 92, 785, 10.1161/01.CIR.92.4.785 Marian, 2003, To screen or not is not the question – it is when and how to screen, Circulation, 107, 2171, 10.1161/01.CIR.0000068686.12195.C2 Van Driest, 2005, Sarcomeric genotyping in hypertrophic cardiomyopathy, Mayo Clin Proc, 80, 463, 10.4065/80.4.463 Girolami, 2006, A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy, J Cardiovasc Med (Hagerstown), 7, 601, 10.2459/01.JCM.0000237908.26377.d6 Garcia-Castro, 2009, Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3 and TPM1 in patients with hypertrophic cardiomyopathy, Rev Esp Cardiol, 62, 48, 10.1016/S0300-8932(09)70020-X Millat, 2010, Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy, Eur J Med Genet, 53, 261, 10.1016/j.ejmg.2010.07.007 Cardim, 2005, Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene, Rev Port Cardiol, 24, 1463 Brito, 2005, Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?, Rev Port Cardiol, 24, 1137 Charron, 1997, Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population, Circulation, 96, 214, 10.1161/01.CIR.96.1.214 Calabrese, 2009, Functional annotations improve the predictive score of human disease related mutations in proteins, Human Mutat, 30, 1237, 10.1002/humu.21047 Tesson, 1997, The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation, J Mol Cell Cardiol, 29, 831, 10.1006/jmcc.1996.0332 Brito, 2003, Familial hypertrophic cardiomyopathy: the same mutation, different prognosis. Comparison of two families with a long follow-up, Rev Port Cardiol, 22, 1445 Watkins, 1992, Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations, J Clin Invest, 90, 1666, 10.1172/JCI116038 Mörner, 2003, Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden, J Mol Cell Cardiol, 35, 841, 10.1016/S0022-2828(03)00146-9 Song, 2005, Mutations profile in Chinese patients with hypertrophic cardiomyopathy, Clin Chim Acta, 351, 209, 10.1016/j.cccn.2004.09.016 Perrot, 2005, Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy, J Mol Med, 83, 468, 10.1007/s00109-005-0635-7 Havndrup, 2003, Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations, Cardiovasc Res, 57, 347, 10.1016/S0008-6363(02)00711-3 Moolman, 1995, Identification of a novel Ala797Thr mutation in exon 21 of the beta-myosin heavy chain gene in hypertrophic cardiomyopathy, Hum Mutat, 6, 197, 10.1002/humu.1380060219 Gruver, 1999, Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation, Am J Cardiol, 83, 13H, 10.1016/S0002-9149(99)00251-9 Ingles, 2005, Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling, J Med Genet, 42, e59, 10.1136/jmg.2005.033886 Watkins, 1995, Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy, N Engl J Med, 332, 1058, 10.1056/NEJM199504203321603 Elliott, 1999, Late-onset hypertrophic cardiomyopathy caused by a mutation in the cardiac troponin T gene, N Engl J Med, 341, 1855, 10.1056/NEJM199912093412416 Theopistou, 2004, Clinical features of hypertrophic cardiomyopathy caused by an Arg278Cys missense mutation in the cardiac troponin T gene, Am J Cardiol, 94, 246, 10.1016/j.amjcard.2004.03.077 Mogensen, 2004, Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy, J Am Coll Cardiol, 44, 2315, 10.1016/j.jacc.2004.05.088 Mogensen, 1999, Sudden cardiac death in familial hypertrophic cardiomyopathy is associated with a novel mutation in the troponin I gene, Circulation, 100 Garcia-Castro, 2003, Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients, Clin Chem, 49, 1279, 10.1373/49.8.1279 Penicka, 2009, The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot randomized study, J Mol Diagn, 11, 35, 10.2353/jmoldx.2009.080082